{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:11:43Z","timestamp":1792617103582,"version":"4.5.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejmech.2021.113741","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T11:17:05Z","timestamp":1627903025000},"page":"113741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["The antibacterial activity of fluoroquinolone derivatives: An update (2018\u20132021)"],"prefix":"10.1016","volume":"224","author":[{"given":"Yanshu","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113741_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118579","article-title":"Roles of long noncoding RNAs in bacterial infection","volume":"263","author":"Wen","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113741_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mpaic.2017.11.002","article-title":"Pharmacological treatment of bacterial infections of the respiratory tract","volume":"19","author":"Barker","year":"2018","journal-title":"Anaesth. Intensive Care Med."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113741_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/acsinfecdis.0c00890","article-title":"Recent innovations in bacterial infection detection and treatment","volume":"7","author":"Deusenbery","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113741_bib4","doi-asserted-by":"crossref","first-page":"40734","DOI":"10.1039\/C7RA06073D","article-title":"Photodynamic antimicrobial chemotherapy with cationic phthalocyanines against Escherichia coli planktonic and biofilm cultures","volume":"7","author":"Li","year":"2017","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113741_bib5","first-page":"709","article-title":"Multidrug-resistant bacteria in the community: an update","volume":"34","author":"van Duin","year":"2020","journal-title":"Infect. Dis. Clin."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113741_bib6","first-page":"7377","article-title":"Multidrug-resistant bacteria in the community: Trends and lessons learned","volume":"30","author":"van Duin","year":"2017","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.ejmech.2021.113741_bib7","series-title":"Tackling Drug-Resistant Infections Globally: Final Report and Recommendations (The Review on Antimicrobial Resistance","author":"O'Neill","year":"2016"},{"issue":"Suppl","key":"10.1016\/j.ejmech.2021.113741_bib8","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: Causes, challenges and responses","volume":"10","author":"Levy","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2021.113741_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nm.4465","article-title":"The role of vaccines in preventing bacterial antimicrobial resistance","volume":"24","author":"Jansen","year":"2018","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113741_bib10","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1021\/acsabm.0c01341","article-title":"Near-infrared light brightens bacterial disinfection: recent progress and perspectives","volume":"4","author":"Han","year":"2021","journal-title":"ACS Appl. Bio. Mater."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113741_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800141","article-title":"Recent updates of fluoroquinolones as antibacterial agents","volume":"351","author":"Ezelarab","year":"2018","journal-title":"Arch. Pharm."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113741_bib12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/jhet.3244","article-title":"4-Quinolone derivatives and their activities against Gram-negative pathogens","volume":"55","author":"Jiang","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","article-title":"4-Quinolone hybrids and their antibacterial activities","volume":"141","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejmech.2018.08.095","article-title":"Recent developments of quinolone-based derivatives and their activities against Escherichia coli","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2021.113741_bib15","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.bmc.2019.05.038","article-title":"Fluoroquinolones structural and medicinal developments (2013-2018): where are we now?","volume":"27","author":"Suaifan","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ejmech.2018.08.061","article-title":"Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib17","first-page":"191","article-title":"Biological activity of amphiphilic metal complexes Coordin","volume":"385","author":"Schattschneider","year":"2019","journal-title":"Chem. Rev."},{"issue":"40","key":"10.1016\/j.ejmech.2021.113741_bib18","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1002\/chem.201904699","article-title":"Enhancing the activity of drugs by conjugation to organometallic fragments","volume":"26","author":"Chellan","year":"2020","journal-title":"Chem. Eur J."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113741_bib19","first-page":"1706","article-title":"Anticancer and antibacterial activity of transition metal complexes","volume":"4","author":"Nandanwar","year":"2019","journal-title":"Chemistry"},{"issue":"31","key":"10.1016\/j.ejmech.2021.113741_bib20","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.2174\/0929867326666190417143533","article-title":"Metal complexes as promising agents for biomedical applications","volume":"27","author":"Loginova","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113741_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.4324","article-title":"New triorganotin(IV) complexes of quinolone antibacterial drug sparfloxacin: synthesis, structural characterization, DFT studies and biological activity","volume":"32","author":"Joshi","year":"2018","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molstruc.2018.04.079","article-title":"Combined experimental and theoretical studies on the diorganotin(IV) complexes of sparfloxacin: synthesis, spectroscopic and DFT studies, and biological activity","volume":"1167","author":"Joshi","year":"2018","journal-title":"J.\u00a0Mol. Struct."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113741_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/hc.21433","article-title":"Interaction of triorganotin(IV) moiety with quinolone antibacterial drug ciprofloxacin: synthesis, spectroscopic investigation, electronic structure calculation, and biological evaluation","volume":"29","author":"Joshi","year":"2018","journal-title":"Heteroat. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113741_bib24","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1039\/d0mt00155d","article-title":"Structural characterization and pharmacological assessment in\u00a0vitro\/in\u00a0vivo of a new copper(II)-based derivative of enrofloxacin","volume":"12","author":"Guo","year":"2020","journal-title":"Metall"},{"issue":"9","key":"10.1016\/j.ejmech.2021.113741_bib25","doi-asserted-by":"crossref","first-page":"e3127","DOI":"10.3390\/ijerph17093127","article-title":"Fluoroquinolone metalloantibiotics: a promising approach against methicillin-resistant Staphylococcus aureus","volume":"17","author":"Bessa","year":"2020","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.ejmech.2021.113741_bib26","article-title":"Antibacterial activity and action mode of Cu(I) and Cu(II) complexes with phosphines derived from fluoroquinolone against clinical and multidrug-resistant bacterial strains","volume":"210","author":"Cal","year":"2020","journal-title":"J.\u00a0Inorg. Biochem."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113741_bib27","doi-asserted-by":"crossref","first-page":"E5998","DOI":"10.1002\/aoc.5998","article-title":"Synthesis, characterization, antimicrobial activity, 3D-QSAR, DFT, and molecular docking of some ciprofloxacin derivatives and their copper(II) complexes","volume":"34","author":"Khalil","year":"2020","journal-title":"Appl. Organomet. Chem."},{"issue":"38","key":"10.1016\/j.ejmech.2021.113741_bib28","doi-asserted-by":"crossref","first-page":"15462","DOI":"10.1039\/C9NJ03178B","article-title":"Copper(II) complexes based on levofloxacin and 2N-donor ligands: synthesis, crystal structures and in\u00a0vitro biological evaluation","volume":"43","author":"Kumar","year":"2019","journal-title":"New J. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113741_bib29","first-page":"422","article-title":"Synthesis and antibacterial studies of ciprofloxacin-metal complexes","volume":"28","author":"Sultana","year":"2019","journal-title":"J.\u00a0Chin. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2021.113741_bib30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.chemosphere.2018.03.117","article-title":"Ciprofloxacin-metal complexes estability and toxicity tests in the presence of humic substances","volume":"202","author":"Cuprys","year":"2018","journal-title":"Chemosphere"},{"issue":"10","key":"10.1016\/j.ejmech.2021.113741_bib31","first-page":"11","article-title":"New bioactive Co(II) and Ni(II) complexes with ofloxacin mixed-ligand","volume":"71","author":"Reiss","year":"2020","journal-title":"Rev. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.07.078","article-title":"Crystal structure and antibacterial activity of polyoxometalate cobalt-ciprofloxacin complex","volume":"1198","author":"Shen","year":"2019","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2021.113741_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.molstruc.2018.02.116","article-title":"Chemical and biological evaluation of moxifloxacin-benzimidazole mixed ligands complexes: anti-cancer and anti-oxidant activities","volume":"1163","author":"Refaat","year":"2018","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2021.113741_bib34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.molliq.2017.11.073","article-title":"Synthesis, spectroscopic, thermal, biological, morphological and molecular docking studies of the different quinolone drugs and their cobalt(II) complexes","volume":"249","author":"Al-Saif","year":"2018","journal-title":"J.\u00a0Mol. Liquids"},{"key":"10.1016\/j.ejmech.2021.113741_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127584","article-title":"Introduction of the antibacterial drugs norfloxacin and Ciprofloxacin into a polyoxometalate structure: synthesis, characterization, and antibacterial activity","volume":"1205","author":"Zou","year":"2020","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2021.113741_bib36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jinorgbio.2019.01.005","article-title":"Synthesis, characterization and biological evaluation of Co(III) complexes with quinolone drugs","volume":"193","author":"Kozsup","year":"2019","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2021.113741_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.110905","article-title":"A\u00a0new calcium(II) complex of marbofloxacin showing much lower acute toxicity with retained antibacterial activity","volume":"203","author":"Xie","year":"2020","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2021.113741_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.poly.2019.03.035","article-title":"Synthesis, characterization and biological activity of Zn coordination compounds with the quinolone gatifloxacin","volume":"166","author":"Kakoulidou","year":"2019","journal-title":"Polyhedron"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113741_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800633","article-title":"Biological investigations and spectroscopic studies of new moxifloxacin\/glycine-metal complexes","volume":"16","author":"Elshafie","year":"2019","journal-title":"Chem. Biodivers."},{"issue":"18","key":"10.1016\/j.ejmech.2021.113741_bib40","doi-asserted-by":"crossref","DOI":"10.1039\/C8NJ01774C","article-title":"New model of metalloantibiotic: synthesis, structure and biological activity of a zinc(II) mononuclear complex carrying two enrofloxacin and sulfadiazine antibiotics","volume":"42","author":"Boughougal","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib41","doi-asserted-by":"crossref","first-page":"e1182","DOI":"10.3390\/molecules23051182","article-title":"Synthesis, spectroscopic, and biological studies of mixed ligand complexes of gemifloxacin and glycine with Zn(II), Sn(II), and Ce(III)","volume":"23","author":"Sakr","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113741_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128300","article-title":"Spectral, structural, biological and molecular docking studies of a new mixed-valence V(IV)\/V(V) ofloxacin complex","volume":"1216","author":"Alikhani","year":"2020","journal-title":"J.\u00a0Mol. Struct."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113741_bib43","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1186\/s40543-018-0147-z","article-title":"Synthesis of moxifloxacin-Au (III) and Ag (I) metal complexes and their biological activities","volume":"9","author":"Seku","year":"2018","journal-title":"J.\u00a0Anal. Sci. Technol."},{"key":"10.1016\/j.ejmech.2021.113741_bib44","article-title":"Experimental and computational studies of the interaction of gemifloxacin and manganese (II) gemifloxacin complex with DNA","volume":"1224","author":"Asadi","year":"2021","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2021.113741_bib45","article-title":"Synthesis, thermogravimetric, and spectroscopic characterizations of three palladium metal(II) ofloxacin drug and amino acids mixed ligand complexes as advanced antimicrobial materials","volume":"1225","author":"Adam","year":"2021","journal-title":"J.\u00a0Mol. Struct."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113741_bib46","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3987\/COM-18-13889","article-title":"Design, synthesis, and biological evaluation of novel 8-methoxyquinolones bearing fused pyrrolidinyl moieties at the C-7 position with potent antibacterial activity against respiratory pathogens","volume":"96","author":"Odagiri","year":"2018","journal-title":"Heterocycles"},{"issue":"16","key":"10.1016\/j.ejmech.2021.113741_bib47","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1021\/acs.jmedchem.8b00644","article-title":"Design, synthesis, and biological evaluation of novel 7-[(3aS, 7aS)-3 a-aminohexahydropyrano[3,4-c]pyrrol-2(3H)-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens","volume":"61","author":"Odagiri","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113741_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1248\/cpb.c18-00671","article-title":"Discovery of novel 7-[(1R,5S)-1-amino-5-fluoro-3-Azabicyclo[3.3.0]octan-3-yl]-6-fluoro-1-[(1R,2S)-2-fluorocyclopropane]-8-(methoxy or methyl)-quinolones","volume":"67","author":"Komoriya","year":"2019","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2021.113741_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102965","article-title":"Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents","volume":"88","author":"T\u00fcre","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.archoralbio.2018.07.015","article-title":"In silico study of Moxifloxacin derivatives with possible antibacterial activity against a resistant form of DNA gyrase from Porphyromonas gingivalis","volume":"95","author":"Rocha-Roa","year":"2018","journal-title":"Arch. Oral Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113741_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40199-018-0226-0","article-title":"N-Substituted piperazinyl sarafloxacin derivatives: synthesis and in\u00a0vitro antibacterial evaluation","volume":"26","author":"Asadipour","year":"2018","journal-title":"DARU J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113741_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1248\/cpb.c17-00717","article-title":"Discovery of a novel fluoroquinolone antibiotic candidate WFQ-228 with potent antimicrobial activity and the potential to overcome major drug resistance","volume":"66","author":"Hirano","year":"2018","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2021.113741_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104629","article-title":"Novel Mannich bases of ciprofloxacin with improved physicochemical properties, antibacterial, anticancer activities and caspase-3 mediated apoptosis","volume":"107","author":"Abdel-Rahman","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113741_bib54","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1134\/S1070363220080265","article-title":"Novel N-4-piperazinyl ciprofloxacin-ester hybrids: synthesis, biological evaluation, and molecular docking studies","volume":"90","author":"Mahdavi","year":"2020","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jhet.3768","article-title":"Theoretical molecular predictions and antimicrobial activities of newly synthesized molecular hybrids of norfloxacin and ciprofloxacin","volume":"57","author":"Bansal","year":"2020","journal-title":"J.\u00a0Heterocycl. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113741_bib56","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11094-018-1837-y","article-title":"Synthesis, antimicrobial activity and QSAR studies of some new sparfloxacin derivatives","volume":"52","author":"Kumar","year":"2018","journal-title":"Pharm. Chem. J."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113741_bib57","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3906\/kim-1706-16","article-title":"New N-4 piperazinyl derivatives of norfloxacin: design, synthesis, and correlation of calculated physicochemical parameters with antibacterial activity","volume":"42","author":"Abuo-Rahma","year":"2018","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib58","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ejmech.2017.10.042","article-title":"Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates","volume":"143","author":"Faidallah","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113741_bib59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1021\/acscombsci.0c00060","article-title":"Synthesis of bioactive complex small molecule-ciprofloxacin conjugates and evaluation of their antibacterial activity","volume":"22","author":"Upadhyay","year":"2020","journal-title":"ACS Comb. Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113741_bib60","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113741_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102952","article-title":"Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity","volume":"88","author":"Mohammed","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113741_bib62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1515\/hc-2018-0070","article-title":"Synthesis and antimicrobial activity evaluation of new norfloxacine-azole hybrids","volume":"24","author":"Demirci","year":"2018","journal-title":"Heterocycl. Commun."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113741_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800261","article-title":"Design, synthesis and antibacterial evaluation of 1-[(1R,2S)-2-fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione hybrids","volume":"15","author":"Gao","year":"2018","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113741_bib64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.33224\/rrch.2019.64.1.10","article-title":"Design, synthesis and antibacterial evaluation of 1-[(1R,2S)-2-fluorocyclopropyl] ciprofloxacin-(4-methyl-3-aryl)-1,2,4-triazole-5(4H)-thione hybrids","volume":"64","author":"Geng","year":"2019","journal-title":"Rev. Roum. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113741_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11030-017-9795-y","article-title":"Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity","volume":"22","author":"Dileep","year":"2018","journal-title":"Mol. Divers."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113741_bib66","first-page":"749","article-title":"Tetrazoles-ciprofloxacin hybrids as antibacterial and antifungal agents","volume":"12","author":"Elavarasan","year":"2018","journal-title":"J.\u00a0Pharm. Res."},{"key":"10.1016\/j.ejmech.2021.113741_bib67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2019.01.072","article-title":"Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation","volume":"167","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib68","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2019.06.046","article-title":"A\u00a0new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV","volume":"179","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113741_bib69","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.31925\/farmacia.2018.6.19","article-title":"Design, synthesis, molecular docking, and antibacterial activity evaluation of some novel norfloxacin analogues","volume":"66","author":"Oniga","year":"2018","journal-title":"FARMACIA"},{"issue":"10","key":"10.1016\/j.ejmech.2021.113741_bib70","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2174\/1570180815666171229150032","article-title":"Synthesis and antibacterial\/antitubercular\/antioxidant activities of compounds containing fluoroquinolone ring linked to a 4-thiazolidinone moiety","volume":"15","author":"Allaka","year":"2018","journal-title":"Lett. Drug Des. Discov."},{"issue":"21","key":"10.1016\/j.ejmech.2021.113741_bib71","doi-asserted-by":"crossref","first-page":"e3959","DOI":"10.3390\/molecules24213959","article-title":"Design, synthesis and biological evaluation of new piperazin-4-yl-(acetyl-thiazolidine-2,4-dione) norfloxacin analogues as antimicrobial agents","volume":"24","author":"Marc","year":"2019","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.ejmech.2021.113741_bib72","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00706-019-02478-4","article-title":"Synthesis, molecular docking, antimicrobial evaluation, and DNA cleavage assay of new thiadiazole\/oxadiazole ciprofloxacin derivatives","volume":"150","author":"Mohammed","year":"2019","journal-title":"Monatshefte fur Chemie"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113741_bib73","first-page":"839","article-title":"Synthesis and evaluation of novel 1,3,4-thiadiazole-fluoroquinolone hybrids as antibacterial, antituberculosis, and anticancer agents","volume":"42","author":"Demirci","year":"2018","journal-title":"Turk. J. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113741_bib74","first-page":"3735","article-title":"Design, synthesis and comparative pharmacological assessment of novel fluoroquinolone derivatives","volume":"10","author":"Majalekar","year":"2019","journal-title":"Int. J. Pharma Sci. Res."},{"key":"10.1016\/j.ejmech.2021.113741_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.104966","article-title":"Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"136","author":"Guo","year":"2019","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113741_bib76","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.3390\/ph14050399","article-title":"Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors","volume":"14","author":"Al-Wahaibi","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.ejmech.2021.113741_bib77","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1039\/C9MD00124G","article-title":"Fluoroquinolone-derived fluorescent probes for studies of bacterial penetration and efflux","volume":"10","author":"Stone","year":"2019","journal-title":"MedChemComm"},{"issue":"10","key":"10.1016\/j.ejmech.2021.113741_bib78","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cmdc.201700739","article-title":"Discovery of benzimidazole-quinolone hybrids as new cleaving agents toward drug-resistant Pseudomonas aeruginosa DNA","volume":"13","author":"Wang","year":"2018","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.ejmech.2021.113741_bib79","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/1573407214666180529124816","article-title":"Synthesis and in\u00a0vitro antibacterial, antitubercular studies of novel fluoroquinolones analogs containing 4-substituted sec amine","volume":"15","author":"Akula","year":"2019","journal-title":"Curr. Bioact. Compd."},{"key":"10.1016\/j.ejmech.2021.113741_bib80","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ejmech.2018.07.025","article-title":"Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids","volume":"156","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113741_bib81","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/jhet.3279","article-title":"Design, synthesis, and antibacterial evaluation of propylene-tethered 8-methoxyl ciprofloxacin-isatin hybrids","volume":"55","author":"Guo","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113741_bib82","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1248\/cpb.c20-00525","article-title":"Design, synthesis and pharmacological evaluation of some C3 heterocyclic-substituted ciprofloxacin derivatives as chimeric antitubercular agents","volume":"68","author":"Niveditha","year":"2020","journal-title":"Chem. Pharm. Bull."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113741_bib83","first-page":"5121","article-title":"Synthesis of Mannich bases of norfloxacin: Conventional and microwave assisted synthesis","volume":"9","author":"Gangrade","year":"2018","journal-title":"Int. J. Pharma Sci. Res."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113741_bib84","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/jhet.3226","article-title":"Design, synthesis, and in\u00a0vitro antibacterial activities of propylene-tethered gatifloxacin-isatin hybrids","volume":"55","author":"Guo","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113741_bib85","doi-asserted-by":"crossref","first-page":"239","DOI":"10.33224\/rrch.2020.65.3.03","article-title":"Gatifloxacin-1,2,3-triazole-isatin hybrids tethered through methylene and acetyl and their antibacterial activities","volume":"65","author":"Guo","year":"2020","journal-title":"Rev. Roum. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103162","article-title":"Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1,2,3-triazole-isatin hybrids","volume":"91","author":"Gao","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113741_bib87","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01170-20","article-title":"In\u00a0vitro and in\u00a0vivo antibacterial activities of a novel quinolone compound, OPS-2071, against Clostridioides difficile","volume":"65","author":"Oka","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"20","key":"10.1016\/j.ejmech.2021.113741_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127428","article-title":"Novel C-7 carbon substituted fourth generation fluoroquinolones targeting N.\u00a0Gonorrhoeae infections","volume":"30","author":"Kirk","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"31","key":"10.1016\/j.ejmech.2021.113741_bib89","first-page":"8930","article-title":"Synthesis and antibacterial evaluation of new pyrimidyl N-ciprofloxacin derivatives","volume":"4","author":"Mokaber-Esfahani","year":"2019","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2021.113741_bib90","first-page":"1065","article-title":"Synthesis and antibacterial activity of 1,3-dione derivatives of 1-cyclopropyl-7-[4-(2,6-dimethyl\/dimethoylpyrimidin-2-yl-diazenyl)-piperzin-1-yl]-6-fluoro-4-oxo-1,4-dihydroquinolone-3-carboxylic acid","volume":"57B","author":"Yadav","year":"2018","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib91","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bioorg.2018.10.033","article-title":"In\u00a0vitro activities of a new fluoroquinolone derivative highly active against Chlamydia trachomatis","volume":"83","author":"Vu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib92","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejmech.2019.06.071","article-title":"Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents","volume":"179","author":"Ciura","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113741_bib93","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40199-020-00373-6","article-title":"Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety","volume":"28","author":"Norouzbahari","year":"2020","journal-title":"DARU, J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113741_bib94","first-page":"3912","article-title":"Synthesis and pharmacological evaluation of some novel 1,2,3,4-tetrahydroquinazolinone derivatives","volume":"11","author":"Rajput","year":"2020","journal-title":"Int. J. Pharma Sci. Res."},{"key":"10.1016\/j.ejmech.2021.113741_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112222","article-title":"Design, synthesis and structure-activity relationships of novel 15-membered macrolides: quinolone\/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides","volume":"193","author":"Fan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2021.113741_bib96","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/jacs.8b01042","article-title":"Esterase-catalyzed siderophore hydrolysis activates an enterobactin-ciprofloxacin conjugate and confers targeted antibacterial activity","volume":"140","author":"Neumann","year":"2018","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113741_bib97","doi-asserted-by":"crossref","first-page":"e1556","DOI":"10.3389\/fmicb.2019.01556","article-title":"Repurposed antimicrobial combination therapy: tobramycin-ciprofloxacin hybrid augments activity of the anticancer drug mitomycin C against multidrug-resistant Gram-negative bacteria","volume":"10","author":"Domalaon","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113741_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112513","article-title":"Design, synthesis and antimicrobial evaluation of novel glycosylated-fluoroquinolones derivatives","volume":"202","author":"Mohammed","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113741_bib99","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1039\/C9MD00051H","article-title":"Polybasic peptide-levofloxacin conjugates potentiate fluoroquinolones and other classes of antibiotics against multidrug-resistant Gram-negative bacteria","volume":"10","author":"Berry","year":"2019","journal-title":"MedChemComm"},{"issue":"13","key":"10.1016\/j.ejmech.2021.113741_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134696","article-title":"Conjugates of ciprofloxacin and levofloxacin with cell-penetrating peptide exhibit antifungal activity and mammalian cytotoxicity","volume":"21","author":"Ptaszy\u0144ska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113741_bib101","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.13005\/ojc\/350401","article-title":"Synthesis of fluoroquinolones derivatives as antimicrobial agents","volume":"35","author":"Swellmeen","year":"2019","journal-title":"Orient. J. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113741_bib102","first-page":"2233","article-title":"Antibiotic-based conjugates containing antimicrobial HLopt2 peptide: design, synthesis, antimicrobial and cytotoxic activities","volume":"14","author":"Ptaszy\u0144ska","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113741_bib103","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/cbdd.13513","article-title":"New fluoroquinolone compounds with endo-nortropine derivatives at C-7 position show antibacterial activity against fluoroquinolone-resistant strains of Staphylococcus aureus","volume":"94","author":"Salunke","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113741_bib104","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2174\/1570180814666171026162304","article-title":"Enhanced antibacterial activity of endo-nortropine substituted (C-7) fluoroquinolones against V.\u00a0cholerae, S. aureus and B.\u00a0subtilis","volume":"15","author":"Salunke","year":"2018","journal-title":"Lett. Drug Des. Discov."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113741_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800273","article-title":"Biology-oriented drug synthesis (BIODS) approach towards synthesis of ciprofloxacin-dithiocarbamate hybrids and their antibacterial potential both in\u00a0vitro and in silico","volume":"15","author":"Esfahani","year":"2018","journal-title":"Chem. Biodivers."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113741_bib106","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11164-018-3598-3","article-title":"New ciprofloxacin-dithiocarbamate-benzyl hybrids: design, synthesis, antibacterial evaluation, and molecular modeling studies","volume":"45","author":"Esfahani","year":"2019","journal-title":"Res. Chem. Intermed."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113741_bib107","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cmdc.201900607","article-title":"Dual Escherichia coli DNA gyrase A and B inhibitors with antibacterial activity","volume":"15","author":"Fois","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113741_bib108","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejmech.2019.01.062","article-title":"Design, synthesis and anti-bacterial studies of piperazine derivatives against drug resistant bacteria","volume":"166","author":"Tahir","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113741_bib109","first-page":"732","article-title":"Design, synthesis and antibacterial activity of fluoroquinolone hydroxamic acids","volume":"28","author":"Shao","year":"2019","journal-title":"Chin. J. New Drugs"},{"key":"10.1016\/j.ejmech.2021.113741_bib110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2018.03.026","article-title":"Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity","volume":"150","author":"Kassab","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113741_bib111","doi-asserted-by":"crossref","first-page":"21","DOI":"10.53879\/id.57.03.12279","article-title":"Design, stnthesis of Schiff base ciprofloxacin-vanillin derivatives as potent bacterial and gyrase inhibitors","volume":"57","author":"Sekhar","year":"2020","journal-title":"Indian Drugs"},{"key":"10.1016\/j.ejmech.2021.113741_bib112","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s43440-020-00193-0","article-title":"Synthesis, antitumor, antibacterial and urease inhibitory evaluation of new piperazinyl N-4 carbamoyl functionalized ciprofloxacin derivatives","volume":"73","author":"Abdel-Aal","year":"2021","journal-title":"Pharmacol. Rep."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113741_bib113","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/00914037.2019.1600517","article-title":"Polymeric bisphosphonate derivative of ciprofloxacin-synthesis, structural analysis and antibacterial activity of the prospective conjugate","volume":"69","author":"Sobczak","year":"2020","journal-title":"Int. J. Polym. Mater."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113741_bib114","first-page":"86","article-title":"Synthesis and antibacterial activity of novel 7-phosphoryl quinolone derivatives","volume":"54","author":"Yang","year":"2019","journal-title":"Chin. Pharmaceut. J."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113741_bib115","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.3390\/antibiotics9110758","article-title":"Membrane-targeting triphenylphosphonium functionalized ciprofloxacin for methicillin-resistant Staphylococcus aureus (MRSA)","volume":"9","author":"Hur","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2021.113741_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111810","article-title":"Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates","volume":"185","author":"Chrzanowska","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113741_bib117","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1039\/C9MD00062C","article-title":"Eradicating uropathogenic Escherichia coli biofilms with a ciprofloxacin-dinitroxide conjugate","volume":"10","author":"Verderosa","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113741_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104658","article-title":"Antibiotic resistance and drug modification: synthesis, characterization and bioactivity of newly modified potent ciprofloxacin derivatives","volume":"108","author":"Alsughayer","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2021.113741_bib119","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.2174\/1877946809666191007125408","article-title":"Novel 7-substituted fluoroquinolone citrate conjugates as powerful antibacterial and anticancer agents: synthesis and molecular docking studies","volume":"23","author":"Allaka","year":"2019","journal-title":"Curr. Org. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113741_bib120","first-page":"3061","article-title":"Synthesis and antibacterial evaluation of new ofloxacin-chalcone derivatives conjugates as possible mutual prodrugs","volume":"10","author":"Hasan","year":"2018","journal-title":"J.\u00a0Pharmaceut. Sci. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113741_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000180","article-title":"Synthesis and antimicrobial evaluation of new nitric oxide-donating fluoroquinolone\/oxime hybrids","volume":"354","author":"Aziz","year":"2021","journal-title":"Arch. Pharm."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:36:51Z","timestamp":1759329411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421005900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":121,"alternative-id":["S0223523421005900"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113741","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antibacterial activity of fluoroquinolone derivatives: An update (2018\u20132021)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113741"}}